CEREGLIDE 92 Intermediate Catheter
Catheter, Percutaneous, Neurovasculature. 510(k) K230726, from Cerenovus, Inc. (Miami, FL). Product code QJP, class 2.
As of Nov 19, 2026, K230726 is an FDA 510(k) held by Cerenovus, Inc., substantially equivalent on Nov 29, 2023 after 258 days, with no recalls tied to it in FDA's recall database.
- Review time: 258 days
- Recalls: 0
- Cited as a predicate by: 1 device
The CEREGLIDE 92 Intermediate Catheter is indicated for use in facilitating the insertion and guidance of appropriately sized interventional devices into a selected blood vessel in the neurovascular system.
- TracStar LDP Large Distal Platform; Zoom 88 Large Distal PlatformK212224 · Imperative Care, Inc. · Sep 20, 2021
- CEREGLIDE 92 Catheter SystemK233982 · Cerenovus, Inc. · May 9, 2024
- NeuroSheathK261449 · Perfuze, Ltd. · Nov 5, 2026
- Excelsior Reach MicrocatheterK261649 · Stryker Neurovascular · Oct 9, 2026
- APRO 88 CatheterK261938 · Alembic, LLC · Oct 6, 2026
- OAB Delivery CatheterK253422 · Cognition Medical Corp. · Oct 2, 2026
- Route 92 Medical Full Length 046 Access SystemK260220 · Route 92 Medical, Inc. · Sep 16, 2026
- 70 NeuGlide CatheterK262277 · Piraeus Medical, Inc. · Sep 4, 2026
- Zoom 4S CatheterK261176 · Imperative Care, Inc. · Aug 28, 2026
- p17 XR MicrocatheterK254071 · Wallaby Medical · Aug 18, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 16, 2023
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1250
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files